Daniel J. George, MD Daniel J. George, MD

Daniel J. George, MD

Medical Oncologist

4.92 out of 5  (422 ratings, 91 reviews)
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-660-0178
Fax number
919-668-8108 Appointments
919-660-0178 Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
919-660-0178 Fax number
WHERE I PROVIDE CARE
Profile
ABOUT ME

I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case.

LANGUAGES I SPEAK
English
LEARN MORE ABOUT ME
Training
EDUCATION
MD, Duke University School of Medicine, 1992
RESIDENCY
Internal Medicine, Johns Hopkins Hospital (Maryland), 1992-1995
FELLOWSHIP
Medical Oncology, Johns Hopkins Hospital (Maryland), 1995-1998
BOARD CERTIFICATION
American Board of Internal Medicine, Medical Oncology
Clinical Focus and Research
MY RESEARCH INTERESTS

I oversee a large clinical research team at Duke focused on developing therapy and improving care and outcomes for patients with urologic cancers, mostly prostate, kidney and bladder cancer. Our work involved both interventional trials with new and emerging therapies as well as diagnostic tests and markers of cancer biology, response and outcome. We have particular interest in immuno-oncology agents as well as targeted therapy. We also are heavily invested in understanding ways to improve the cancer experience for patients including many lifestyle interventions and supports. We have a significant proportion of African American patients and have a particular interest in understanding the differences in their disease and improving care delivery for this population. Our diverse team includes other physicians as well as clinical research nurses, data managers, and regulatory and other allied health services staff.

Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall provider rating
4.92 out of 5 (422 ratings, 91 reviews)
PATIENT REVIEWS
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • Acceleron Pharma
  • Astellas Pharma Inc.
  • Axess Oncology
  • Bayer Healthcare Pharmaceuticals
  • Bristol-Myers Squibb Cojmpany
  • Exelixis, Inc.
  • Innocrin Pharmaceuticals ( spin-off of Viamet)
  • Janssen Pharmaceuticals (Johnson & Johnson)
  • Merck
  • Myovant Sciences, Inc
  • National Cancer Intitute
  • Pfizer Inc.
  • Sanofi-Aventis